Acumen Pharmaceuticals, Inc.

Regulation FD Disclosure

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Regulation FD Disclosure

Submission of Matters to a Vote of Security Holders

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Annual Report Scanned (Paper)

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Notice of Effectiveness

Prospectus Supplement for Primary Offering

Letter from the SEC

Correspondence with the SEC

Annual report pursuant to Section 13 or 15(d)

Results of Operations and Financial Condition

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement under Securities Act of 1933

Beneficial ownership report for a holder of more than 5% (Schedule 13D) (amendment)

Entry into a Material Definitive Agreement

Regulation FD Disclosure

Prospectus Supplement for Primary Offering

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Entry into a Material Definitive Agreement

Submission of Matters to a Vote of Security Holders

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Annual Report Scanned (Paper)

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Annual report pursuant to Section 13 or 15(d)

Results of Operations and Financial Condition

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

General form for quarterly reports under Section 13 or 15(d)

2.02,7.01,9.01

General form for quarterly reports under Section 13 or 15(d)

2.02,7.01,9.01

5.07

General form for quarterly reports under Section 13 or 15(d)

2.02,7.01,9.01

Notice of Effectiveness

Annual Report Scanned (Paper)

Correspondence with the SEC

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Letter from the SEC

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement under Securities Act of 1933

Annual report pursuant to Section 13 or 15(d)

2.02,9.01

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

General form for quarterly reports under Section 13 or 15(d)

Additional Information for Proxy Statement/ Votes

Annual Report Scanned (Paper)

Definitive Proxy Statement

Prospectus Supplement for Primary Offering

Preliminary Proxy Statement

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Annual report pursuant to Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Notice of Effectiveness

Letter from the SEC

Correspondence with the SEC

Registration statement under Securities Act of 1933

General form for quarterly reports under Section 13 or 15(d)

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Annual report pursuant to Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement with Pricing Information

No description available

No description available

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

No description available

Draft registration statement (confidential submission) (amendment)

Letter from the SEC

Porter Derrell

Porter Derrell

Porter Derrell

Porter Derrell

Fountain Nathan B

Fountain Nathan B

Stalfort John A III

RA Capital Healthcare Fund LP; RA CAPITAL MANAGEMENT, L.P.; RA Capital Nexus Fund II, L.P.; Kolchinsky Peter; Shah Rajeev M.

Fountain Nathan B

Drapkin Kimberlee C

Golumbeski George

Porter Derrell

Ives Jeffrey L.

Stoppel Laura

RA Capital Healthcare Fund LP; RA CAPITAL MANAGEMENT, L.P.; RA Capital Nexus Fund II, L.P.; Kolchinsky Peter; Shah Rajeev M.

Meisner Derek M

Meisner Derek M

Meisner Derek M